Evaluation of urinary oxalate levels in patients receiving gastrointestinal lipase inhibitor.

Sarica, Kemal; Akarsu, Ersin; Erturhan, Sakip; Yagci, Faruk; Aktaran, Sebnem; Altay, Bulent

Sarica, Kemal; Akarsu, Ersin; Erturhan, Sakip; Yagci, Faruk; Aktaran, Sebnem; Altay, Bulent.

Affiliation

Sarica K; Department of Urology, Memorial Hospital, Istanbul, Turkey. kemalsarica@superonline.com

Obesity (Silver Spring) ; 16(7): 1579-84, 2008 Jul.

Article in En | MEDLINE | ID: mdl-18451780

Subject(s)

Anti-Obesity Agents/adverse effects; Enzyme Inhibitors/adverse effects; Hyperoxaluria/chemically induced; Intestines/drug effects; Lactones/adverse effects; Lipase/antagonists & inhibitors; Obesity/drug therapy; Oxalic Acid/urine; Adult; Calcium/urine; Citric Acid/urine; Female; Humans; Hyperoxaluria/metabolism; Intestinal Absorption/drug effects; Intestines/enzymology; Lipase/metabolism; Male; Obesity/metabolism; Orlistat; Risk Assessment; Treatment Outcome; Up-Regulation; Urinary Calculi/chemically induced

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hyperoxaluria / Anti-Obesity Agents / Oxalic Acid / Enzyme Inhibitors / Intestines / Lactones / Lipase / Obesity Type of study: Clinical_trials / Etiology_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male Language: En Journal: Obesity (Silver Spring) Journal subject: CIENCIAS DA NUTRICAO / FISIOLOGIA / METABOLISMO Year: 2008 Document type: Article Affiliation country: Turkey

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google